Screener
Nuvation Bio NUVB Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Nuvation Bio’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:55 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336646
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Property and equipment, net of accumulated depreciation of $1,331 and $1,184, respectively | 715 | 564 |
| Intangible assets, net of accumulated amortization of $2,777 and $1,856, respectively | 10,292 | 11,214 |
| Operating lease right-of-use assets | 3,240 | 3,918 |
| Other non-current assets | 3,824 | 7,607 |
| Total assets | $744,503 | $594,822 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $12,089 | $9,479 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's deferred tax assets and other non-current assets?
- Nuvation Bio (NUVB) reported deferred tax assets and other non-current assets of $3.82M in Q2 2026.
- How has Nuvation Bio's deferred tax assets and other non-current assets changed year-over-year?
- Nuvation Bio's deferred tax assets and other non-current assets decreased by 42.2% year-over-year, from $6.62M to $3.82M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Nuvation Bio's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude